• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: IRIDEX CORPORATION G-PROBE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

IRIDEX CORPORATION G-PROBE Back to Search Results
Model Number 15980-1
Medical Device Problem Code Contamination /Decontamination Problem (2895)
Health Effect - Clinical Codes Eye Injury (1845); Eye Burn (2523)
Date of Event 02/26/2024
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
810 nm ophthalmic laser systems are intended to deliver thermal (laser) energy to deliver an insult (burn) to the ciliary body.Conjunctival burns are a known and predicted complication associated with the use of any 810nm ophthalmic laser system (console and delivery device) when used to deliver transscleral treatment.Conjunctival burns are typically superficial andtypically pose no long-term threat to the patient (i.E., no adverse effect on patient disease state, no requirement for additionalfuture care).Typically, these burns resolve within 24-48 hours post op without additional intervention.The result of these burns requires no post-operative management nor change to the post-operative medication regimen within the normal post-operative appointment schedule.The most likely cause of the reported adverse event is suspected to be contamination (e.G., blood, tissue or betadine) on the probe tip when the laser was activated.The g-probe delivery device ifu warns that contamination at the tip may cause ophthalmic burns: "contamination of the fiber optic tip by blood or tissue char may result in ocular surface burns.Excessive energy may cause equatorial burns.Heavy perilimbal conjunctival pigmentation may result in local absorption and burns;therefore, avoid areas of heavy perilimbal pigmentation".
 
Event or Problem Description
A 55 year male patient with a known history of moderate primary open angle glaucoma experienced two conjunctival burns in the right eye during treatment with the cyclo g6 laser console and the g-probe delivery device.As reported by the complainant, " on strarting the treatment,patient observed to have conjunctival burns.Probe was inspected and observed to be smoking, even at 1600 mw.Probe discontinued.New probe connected.Treatment completed with new probe." a retrobulbar block anesthetic was applied during the procedure, no vasconstrictor, liquid coupling agent or betadine solution was used.There was no subconjunctival hemorrhage or bleeding present in the surgical field during treatment.It is unknown if the user observed any pigmented legions or dark areas in the surgical field.The patient is recovering well and did not require any further managment.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
G-PROBE
Common Device Name
G-PROBE
Manufacturer (Section D)
IRIDEX CORPORATION
1212 terra bella ave
mountain view CA 94043 1824
Manufacturer (Section G)
IRIDEX CORPORATION
1212 terra bella ave
mountain view CA 94043 9149
Manufacturer Contact
nimrta tandan
1212 terra bella ave
moutntain view, CA 94043-9194
MDR Report Key19525238
Report Number2939653-2024-00013
Device Sequence Number18043982
Product Code GEX
UDI-Device Identifier00813125015237
UDI-Public00813125015237
Combination Product (Y/N)N
Initial Reporter StateTX
Initial Reporter CountryUS
PMA/510(K) Number
K915236
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional
Initial Reporter Occupation Nurse
Type of Report Initial
Report Date (Section B) 06/04/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Model Number15980-1
Device Lot Number200202
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 03/07/2024
Initial Report FDA Received Date06/12/2024
Was Device Evaluated by Manufacturer? (Y/N) No
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Unknown
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient Age55 YR
Patient SexMale
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-